HansBiomed Thailand is 1 of 7 branch offices under
Head office located in
The sales of Hans Biomed Co. have grown around 25% for the last 5 years in a row, holding a stable financial position. Starting R&D investment in new medical treatments and technology relate to regenerative medicine as well as tissue engineering, Hans Biomed has prepared itself for a new challenge for the better health of humankind.
Establishing Korea’s first tissue bank acquired permission for establishing Korea’s first tissue bank from the Ministry of Food and Drug Safety (MFDS) in 2005. Although there were several companies, research institutions, and universities, at that time, studying in relation to tissue engineering such as artificial organs, we acquired the first permission for establishing a tissue bank in Korea. In particular, human tissue transplants are kept sterile and aseptic in the tissue bank. We, as a specialized company furnished with well-managed clean rooms and professional personnel, acquired the establishment of a tissue bank and thus contribute to the domestic industry related to human tissue transplant.
Registered to The U.S. FDA Registered to The U.S. Food and Drug Administration (FDA) in 2002From the U.S.FDA that conducts field inspection on quality management, production facility, production lines, safety, etc. on regular basis, Biomed Co., Ltd. received
Selected as “World Top-Class Product Company” sponsored by the Ministry of Commerce, Industry and Energy in 2002 and 2010.Hans Biomed Co.’s receiving the award (World Top-Class Product Company) implies that it was acknowledged as an excellent export-driven company, which was the first for a venture company that produces human tissue transplants.